TrialInitiating Early Control of Migraine Pain and Associated Symptoms
Trial details
- Registry ID
- NCT04163185
- Phase
- Phase 3
Drug research
AXS-07 (MoSEIC meloxicam and rizatriptan)
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
Also recorded as AXS-07; MoSEIC meloxicam and rizatriptan
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Initiating Early Control of Migraine Pain and Associated SymptomsNCT04163185 | AXSM | Phase 3 | Completed | 2020-03-16Actual |
| Maximizing Outcomes in Treating Acute MigraineNCT03896009 | AXSM | Phase 3 | Completed | 2019-12-10Actual |
Maximizing Outcomes in Treating Acute Migraine
Trial details
- Registry ID
- NCT03896009
- Phase
- Phase 3
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |